<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000045340">
  <TermName>iododoxorubicin</TermName>
  <TermPronunciation>(I-oh-doh-DOK-soh-ROO-bih-sin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied as a treatment for cancer and for primary systemic amyloidosis (a disease in which proteins are deposited in specific organs). It is a type of anthracycline antitumor antibiotic.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000705343" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;iododoxorubicin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000705342" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;iododoxorrubicina&quot;" language="es" id="_4"/>
  <SpanishTermName>iododoxorrubicina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del cáncer y la amiloidosis sistémica primaria (enfermedad en que las proteínas se depositan en órganos específicos). Es un tipo de antibiótico antitumoral de antraciclina.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2007-03-09</DateLastModified>
</GlossaryTerm>
